Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nutritional Care of Patients with Parkinson's Disease.

Nutrition reviews·2026

Same author

Current application and future directions for the sarcopenic obesity Global Leadership Initiative (SOGLI) diagnostic algorithm.

Clinical nutrition (Edinburgh, Scotland)·2026

Same author

Muscle Health and Prognosis in Patients With Cancer: New Insights.

Journal of cachexia, sarcopenia and muscle·2026

Same author

Body mass index in the Italian population of patients with Parkinson's disease.

Nutritional neuroscience·2026

Same author

Sex Differences in Levodopa-Sparing Effect of Safinamide: Post-hoc Findings from a Multicenter, Longitudinal, Case-Control Study.

Movement disorders clinical practice·2026

Same author

Correlations Between Clinical, Anthropometric and Nutritional Evaluations in Patients with Parkinson's Disease from Ghana: A Cross-Sectional Study.

Journal of clinical medicine·2026

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Frailty Assessment in an Aging Mouse Model

Frailty Assessment in an Aging Mouse Model

Published on: September 23, 2025

The Geriatric Nutritional Risk Index.

Emanuele Cereda¹, Carlo Pedrolli

¹International Center for the Assessment of Nutritional Status, University of Milan, Milan, Italy. emanuele.cereda@virgilio.it

Current Opinion in Clinical Nutrition and Metabolic Care

|December 6, 2008

Summary

The Geriatric Nutritional Risk Index (GNRI) is a new, easy-to-use tool for assessing nutritional risk in older adults. Preliminary findings suggest it effectively identifies at-risk patients, aiding in timely nutritional support.

Related Experiment Videos

Last Updated: Jun 27, 2026

Frailty Assessment in an Aging Mouse Model

Frailty Assessment in an Aging Mouse Model

Published on: September 23, 2025

Area of Science:

Geriatric Medicine
Nutritional Science
Clinical Assessment Tools

Background:

Malnutrition is a significant concern in elderly healthcare.
Accurate nutritional risk assessment is crucial for timely intervention.
Existing assessment methods can be challenging with elderly patients.

Purpose of the Study:

To review current evidence on the Geriatric Nutritional Risk Index (GNRI).
To explore the rationale for using GNRI in elderly healthcare.
To summarize the application and effectiveness of GNRI.

Main Methods:

The review synthesizes data on the GNRI's structure and application.
It examines the GNRI's ability to identify nutritional risk in elderly individuals.
Evidence on its feasibility across healthcare settings is considered.

Main Results:

The GNRI is a dichotomous index using serum albumin and weight discrepancy.
It addresses challenges in patient participation during nutritional assessments.
A GNRI below 92 is proposed as a trigger for nutritional support.
The tool effectively discriminates various nutritional risk profiles.

Conclusions:

The 'recognize and treat' approach to nutrition is a clinical imperative.
While expert judgment remains the standard, simplified tools like GNRI aid screening.
GNRI is user-friendly and shows promising preliminary results.
Routine use of GNRI alongside other tools is recommended for elderly patient assessment.